Xiuying Yang
State Key Laboratory Of Bioactive Substance And Function Of Natural Medicines, Chinese Academy Of Medical Sciences And Peking Union Medical College And Beijing Key Laboratory Of Innovative Drug Discovery And Polymorphic Druggability Research For Cerebrovascular Diseases
Beijing, 100050, China
Beijing, 100050, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
The complete chloroplast genome and phylogenetic analysis of Schisandra henryi C. B. Clarke.
Journal: Mitochondrial DNA. Part B, Resources
Published: February 02, 2026
Jiangtang Tiaozhi Formula alleviates obesity by enhancing adipose thermogenesis via TGR5-mediated gut-liver-adipose axis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: August 20, 2025
New tetrahydroanthraquinones and γ-butenolides from the fungus Auxarthron umbrinum DSM3193.
Journal: Chinese journal of natural medicines
Published: August 10, 2024
Exercise-induced BDNF promotes PPARδ-dependent reprogramming of lipid metabolism in skeletal muscle during exercise recovery.
Journal: Science signaling
Published: March 19, 2024
Kaempferol attenuates nonalcoholic fatty liver disease in type 2 diabetic mice via the Sirt1/AMPK signaling pathway.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 24, 2023
Versatile Solid Modifications of Multicomponent Pharmaceutical Salts: Novel Metformin-Rhein Salts Based on Advantage Complementary Strategy Design.
Journal: Pharmaceutics
Published: February 20, 2023
Combination of Docking-Based and Pharmacophore-Based Virtual Screening Identifies Novel Agonists That Target the Urotensin Receptor.
Journal: Molecules (Basel, Switzerland)
Published: November 08, 2022
Urotensin receptor acts as a novel target for ameliorating fasting-induced skeletal muscle atrophy.
Journal: Pharmacological research
Published: August 09, 2022
Uncovering the effect and mechanism of Panax notoginseng saponins on metabolic syndrome by network pharmacology strategy.
Journal: Journal of ethnopharmacology
Published: June 14, 2022
Antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid-induced skeletal muscle atrophy.
Journal: Clinical and translational medicine
Published: February 26, 2022
Src homology 3 domain binding kinase 1 protects against hepatic steatosis and insulin resistance through the Nur77-FGF21 pathway.
Journal: Hepatology (Baltimore, Md.)
Published: February 19, 2022
Last Updated: 09/26/2026